Scientific Advisory Board
Ron R. Allison, MD
Chief Medical Advisor
Dr. Allison is a board certified Radiation Oncologist. Dr. Allison is the former Professor and Chair of Radiation Oncology at the Brody School of Medicine at the University of North Carolina and former Director of the Leo W. Jenkins Cancer Center. Dr. Allison has authored over 100 oncology publications and has delivered over 200 presentations at oncology meetings and forums worldwide. Dr. Allison's area of expertise is photodynamic therapy. He has been a principle investigator for multiple PDT clinical trials, treated numerous patients with PDT and served as a reviewer and editor of grants and articles in this domain. He was a clinical investigator in the REM-001 Therapy clinical trials in CMBC.
Leonard A. Farber, MD
Dr. Farber is a board certified physician in Radiation Oncology and an Assistant Professor in the Department of Radiation Oncology at Cornell Weill Hospital. Dr. Farber previously served as the Chairman of Radiation Oncology at Staten Island University Hospital. Dr. Farber specializes in adult radiation oncology, with particular focus on breast and gastrointestinal malignancies, lymphomas, lung cancers, and head and neck cancer. He also has expertise in high dose rate brachytherapy for various types of cancers, including breast, skin, and gynecologic malignancies, and intracranial and body stereotactic radiation therapy.
Thomas S. Mang, PhD
Dr. Mang is an Associate Professor and Director of Research for the Oral and Maxillofacial Surgery Department at the University at Buffalo (UB), School of Dental Medicine. He is also the Director of the Great Lakes Biomedical Laser Center at the UB School of Dental Medicine. Dr. Mang previously served as Director of the PDT Clinic at Roswell Park Cancer Institute in Buffalo, NY. Dr. Mang is an expert in PDT with over 30 years of experience and has experience in the corporate aspects of PDT, having previously held the position of Clinical Manager for PDT at Axcan Pharma Inc. He was also engaged in prior clinical work with REM-001 Therapy.
Roman Perez-Soler, MD
Dr. Perez-Soler has been the Gutman Professor of Oncology and Chairman of the Department of Oncology at Montefiore Medical Center, and Professor of Medicine and Molecular Pharmacology and Chief of the Division of Medical Oncology at the Albert Einstein College of Medicine since July 2001. He is currently Deputy Director of the Albert Einstein Cancer Center. Dr. Perez-Soler is also currently a member of the Board of Scientific Advisors of the National Cancer Institute. Dr. Perez-Soler is an inventor in 17 patents and is well known in cancer research with over 200 scientific publications and several book chapters related to the fields of drug delivery and targeted therapies for solid tumors. His work in the field of anti-epidermal growth factor receptor therapies has received a myriad of citations. He has been the co-founder of two pharmaceutical companies, Argus Pharmaceuticals, Inc. and Transave, Inc. and has served as a consultant to a large number of pharmaceutical companies. He served as a director for Transave, Inc. from 2000 to 2006. Dr. Perez-Soler earned his M.D. from Universidad Autonoma in Barcelona, where he also completed a residency in internal medicine. He completed his fellowship in Medical Oncology at the University of Texas, M.D. Anderson Hospital Cancer Center and is a past Fulbright Scholar.
Stephen B. Solomon, MD
Dr. Solomon is Chief of Interventional Radiology in the Department of Radiology at Memorial Sloan Kettering and is the Co-Director of Memorial Sloan Kettering’s Center for Image-Guided Intervention. As an interventional radiologist, Dr. Solomon specializes in minimally invasive treatments carried out using image guidance, including x-ray, CT, ultrasound, and MRI and has expertise in robotics and other image-guided therapies. During his career, he has authored over 200 articles in peer-reviewed scientific journals and has been the principal investigator on multiple clinical trials in cancer.